TRADING AND AVAILABLE-FOR-SALE SECURITIES AT FAIR VALUE (Tables)
|
6 Months Ended |
Sep. 30, 2024 |
Debt Securities, Trading, and Equity Securities, FV-NI [Abstract] |
|
Schedule of trading and available-for-sale securities |
As of September 30, 2024, and March 31, 2024, trading and available-for-sale securities consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2024 |
|
March 31, 2024 |
|
|
|
|
Non-U.S. sovereign debt |
$ |
2,353,084 |
|
|
$ |
2,409,126 |
|
Corporate debt |
1,071,502 |
|
|
1,108,870 |
|
Corporate equity |
128,434 |
|
|
126,103 |
|
U.S. sovereign debt |
41,442 |
|
|
43,173 |
|
Exchange traded notes |
6,656 |
|
|
1,348 |
|
Total trading securities |
$ |
3,601,118
|
|
|
$ |
3,688,620
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2024 |
|
March 31, 2024 |
|
|
|
|
Corporate debt |
$ |
184,556 |
|
|
$ |
173,568 |
|
Non-U.S. sovereign debt |
78,446 |
|
|
27,016 |
|
U.S. sovereign debt |
21,578 |
|
|
16,037 |
|
Total available-for-sale securities, at fair value |
$ |
284,580
|
|
|
$ |
216,621
|
|
|
Schedule of maturity of available for sale securities |
The following tables present maturity analysis for available-for-sale securities as of September 30, 2024, and March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2024 |
|
Remaining contractual maturity of the agreements |
|
Up to 1 year |
|
1-5 years |
|
5-10 years |
|
More than 10 years |
|
Total |
|
|
|
|
|
|
|
|
|
|
Corporate debt |
29,395 |
|
|
98,466 |
|
|
52,424 |
|
|
4,271 |
|
|
184,556 |
|
Non-US sovereign debt |
17,764 |
|
|
17,675 |
|
|
36,100 |
|
|
6,907 |
|
|
78,446 |
|
US sovereign debt |
— |
|
|
11,946 |
|
|
8,357 |
|
|
1,275 |
|
|
21,578 |
|
Total available-for-sale securities, at fair value |
$ |
47,159
|
|
|
$ |
128,087
|
|
|
$ |
96,881
|
|
|
$ |
12,453
|
|
|
$ |
284,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
Remaining contractual maturity of the agreements |
|
Up to 1 year |
|
1-5 years |
|
5-10 years |
|
More than 10 years |
|
Total |
|
|
|
|
|
|
|
|
|
|
Corporate debt |
65,415 |
|
|
44,374 |
|
|
59,553 |
|
|
4,226 |
|
|
173,568 |
|
Non-US sovereign debt |
7,839 |
|
|
7,310 |
|
|
5,797 |
|
|
6,070 |
|
|
27,016 |
|
US sovereign debt |
— |
|
|
5,059 |
|
|
9,753 |
|
|
1,225 |
|
|
16,037 |
|
Total available-for-sale securities, at fair value |
$ |
73,254
|
|
|
$ |
56,743
|
|
|
$ |
75,103
|
|
|
$ |
11,521
|
|
|
$ |
216,621
|
|
|
Schedule of present securities assets at fair value |
The following tables present securities assets in the Сondensed Сonsolidated Balance Sheets or disclosed in the Notes to the condensed consolidated financial statements at fair value on a recurring basis as of September 30, 2024, and March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Interest Rate |
|
Total |
|
Fair Value Measurements as of September 30, 2024 using |
|
|
|
Quoted Prices in Active Markets for Identical Assets |
|
Significant Other Observable Inputs |
|
Significant Unobservable Units |
|
|
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
|
|
|
|
|
|
|
|
|
|
Non-U.S. sovereign debt |
12.05 |
% |
|
$ |
2,353,084 |
|
|
$ |
2,090,214 |
|
|
$ |
262,870 |
|
|
$ |
— |
|
Corporate debt |
13.96 |
% |
|
1,071,502 |
|
|
336,376 |
|
|
734,754 |
|
|
372 |
|
Corporate equity |
|
|
128,434 |
|
|
106,526 |
|
|
3,513 |
|
|
18,395 |
|
U.S. sovereign debt |
3.62 |
% |
|
41,442 |
|
|
41,442 |
|
|
— |
|
|
— |
|
Exchange traded notes |
|
|
6,656 |
|
|
6,132 |
|
|
524 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total trading securities |
|
|
$ |
3,601,118
|
|
|
$ |
2,580,690
|
|
|
$ |
1,001,661
|
|
|
$ |
18,767
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
14.23 |
% |
|
$ |
184,556 |
|
|
$ |
56,457 |
|
|
$ |
128,099 |
|
|
$ |
— |
|
Non-US sovereign debt |
11.31 |
% |
|
78,446 |
|
|
56,694 |
|
|
21,752 |
|
|
— |
|
US sovereign debt |
2.68 |
% |
|
21,578 |
|
|
21,578 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities, at fair value |
|
|
$ |
284,580
|
|
|
$ |
134,729
|
|
|
$ |
149,851
|
|
|
$ |
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
Interest Rate
|
|
Total |
|
Fair Value Measurements as of March 31, 2024 using |
|
|
|
Quoted Prices in Active Markets for Identical Assets |
|
Significant Other Observable Inputs |
|
Significant Unobservable Units |
|
|
|
(Level 1) |
|
(Level 2) |
|
(Level 3) |
|
|
|
|
|
|
|
|
|
|
Non-U.S. sovereign debt |
11.61 |
% |
|
$ |
2,409,126 |
|
|
$ |
1,592,380 |
|
|
$ |
816,746 |
|
|
$ |
— |
|
Corporate debt |
14.83 |
% |
|
1,108,870 |
|
|
171,218 |
|
|
937,360 |
|
|
292 |
|
Corporate equity |
|
|
126,103 |
|
|
102,134 |
|
|
3,819 |
|
|
20,150 |
|
U.S. sovereign debt |
4.98 |
% |
|
43,173 |
|
|
43,173 |
|
|
— |
|
|
— |
|
Exchange traded notes |
|
|
1,348 |
|
|
1,045 |
|
|
303 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total trading securities |
|
|
$ |
3,688,620
|
|
|
$ |
1,909,950
|
|
|
$ |
1,758,228
|
|
|
$ |
20,442
|
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
15.53 |
% |
|
$ |
173,568 |
|
|
$ |
47,135 |
|
|
$ |
126,433 |
|
|
$ |
— |
|
Non-U.S. sovereign debt |
10.48 |
% |
|
27,016 |
|
|
12,378 |
|
|
14,638 |
|
|
— |
|
U.S. sovereign debt |
3.54 |
% |
|
16,037 |
|
|
16,037 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
Total available-for-sale securities, at fair value |
|
|
$ |
216,621
|
|
|
$ |
75,550
|
|
|
$ |
141,071
|
|
|
$ |
—
|
|
|
Schedule of valuation techniques and significant level 3 inputs |
The tables below present the valuation techniques and significant Level 3 inputs used in the valuation as of September 30, 2024, and March 31, 2024. The tables are not intended to be all inclusive, but instead capture the significant unobservable inputs relevant to determination of fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type |
|
Valuation Technique |
|
FV as of September 30, 2024 |
|
Significant Unobservable Inputs |
|
% |
|
|
|
|
|
|
|
|
|
Corporate debt |
|
DCF |
|
372 |
|
|
Discount rate |
|
74.0% |
|
|
|
|
|
|
Estimated number of years |
|
3 months |
Corporate equity |
|
DCF |
|
18,262 |
|
|
Discount rate |
|
13.0% |
|
|
|
|
|
|
Estimated number of years |
|
4 years, 3 months |
|
|
|
|
|
|
Termination multiplier |
|
26.8x |
Corporate equity |
|
DCF |
|
133 |
|
|
Discount rate |
|
58.8% |
|
|
|
|
|
|
Estimated number of years |
|
9 years |
Total |
|
|
|
$ |
18,767
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Type |
|
Valuation Technique |
|
FV as of March 31, 2024 |
|
Significant Unobservable Inputs |
|
% |
|
|
|
|
|
|
|
|
|
Corporate debt |
|
DCF |
|
$ |
292 |
|
|
Discount rate |
|
74.0% |
|
|
|
|
|
|
Estimated number of years |
|
3 months |
Corporate equity |
|
DCF |
|
20,007 |
|
|
Discount rate |
|
13.0% |
|
|
|
|
|
|
Estimated number of years |
|
4 years, 6 months |
|
|
|
|
|
|
Termination multiplier |
|
27x |
Corporate equity |
|
DCF |
|
143 |
|
|
Discount rate |
|
58.8% |
|
|
|
|
|
|
Estimated number of years |
|
9 years |
Total |
|
|
|
$ |
20,442
|
|
|
|
|
|
The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the six months ended September 30, 2024, and the year ended March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
Trading securities |
Balance as of March 31, 2023 |
|
$ |
5,138
|
|
|
|
|
Reclassification to Level 2 |
|
$ |
(32) |
|
Deconsolidation of Freedom UA securities |
|
(3,927) |
|
Sale of investments that use Level 3 inputs |
|
(15,856) |
|
Purchase of investments that use Level 3 inputs |
|
35,807 |
|
Revaluation of investments that use Level 3 inputs |
|
(132) |
|
Reclassification to investment in associate |
|
(556) |
|
Balance as of March 31, 2024 |
|
$ |
20,442
|
|
|
|
|
Reclassification to Level 3 |
|
— |
|
Sale of investments that use Level 3 inputs |
|
— |
|
Purchase of investments that use Level 3 inputs |
|
— |
|
Revaluation of investments that use Level 3 inputs |
|
(1,675) |
|
Balance as of September 30, 2024 |
|
$ |
18,767
|
|
|
Schedule of amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities |
The table below presents the amortized cost, unrealized gains and losses accumulated in other comprehensive income, and fair value of available-for-sale securities as of September 30, 2024, and March 31, 2024:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2024 |
|
|
|
|
Assets measured at amortized cost |
|
Accumulated impairment loss |
|
Unrealized loss accumulated in other comprehensive income/(loss) |
|
Assets measured at fair value |
|
Maturity Date |
|
|
|
|
|
|
|
|
|
|
|
Corporate debt |
|
$ |
182,778 |
|
|
$ |
(47) |
|
|
$ |
1,825 |
|
|
$ |
184,556 |
|
|
2024-2039 |
Non-US sovereign debt |
|
78,083 |
|
|
(314) |
|
|
677 |
|
|
78,446 |
|
|
2025-indefinite |
U.S. sovereign debt |
|
21,813 |
|
|
— |
|
|
(235) |
|
|
21,578 |
|
|
2027-2044 |
Total available-for-sale securities, at fair value |
|
$ |
282,674
|
|
|
$ |
(361) |
|
|
2,267
|
|
|
$ |
284,580
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2024 |
|
|
|
|
Assets measured at amortized cost |
|
Accumulated impairment loss |
|
Unrealized loss accumulated in other comprehensive income/(loss) |
|
Assets measured at fair value |
|
Maturity Date |
|
|
|
|
|
|
|
Corporate debt |
|
$ |
172,689 |
|
|
$ |
(61) |
|
|
$ |
940 |
|
|
$ |
173,568 |
|
|
2024-2039 |
Non-U.S. sovereign debt |
|
29,121 |
|
|
(352) |
|
|
(1,753) |
|
|
27,016 |
|
|
2024-indefinite |
U.S. sovereign debt |
|
16,767 |
|
|
— |
|
|
(730) |
|
|
16,037 |
|
|
2027-2044 |
Total available-for-sale securities, at fair value |
|
$ |
218,577
|
|
|
$ |
(413) |
|
|
$ |
(1,543) |
|
|
$ |
216,621
|
|
|
|
|